ArticleJournal, genetic engineering & biotechnology2025
Assessment of the gold nanoparticles biosynthesized using Casuarina equisetifolia bark extract against the ethion induced Hepato- and neurotoxicity in rats.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of the biological efficacy of gold Nannochloropsis oculata nano-extract against lithium-induced toxicity in rats.Scientific reports · 2026Article
- Zinc Sulfate Alleviates Olanzapine Induced Alteration in Hepatic Protein Patterns and Antioxidant Defense System in Rats.Biological trace element research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ethion (Etn) is classified as an organophosphate pesticide (OP) that causes toxicity even at low concentrations and targets the liver, brain, kidney, and blood. Gold nanoparticles (Au-NPs) were biosynthesized from the whole methanolic extract of Casuarina equisetifolia bark, and their efficacy against Etn-induced hepato- and neurotoxicity in rats was assessed. In addition to determining conventional biochemical measurements, the target tissues (liver and brain) were examined for oxidative stress, inflammatory, and fibrotic markers. The protein and isoenzyme patterns were also assayed using an electrophoretic technique. Additionally, apoptotic gene expression was measured. The target tissues were also subjected to histopathological analysis. In all groups treated with C. equisetifolia bark gold nano-extract, it was observed that the levels of the hematological measurements that were impacted by the oral injection of Etn had recovered to normal. Regarding the biochemical measurements, the group that received nano-extract pretreatment showed greater improvement than the therapeutic group. The levels of inflammatory indicators significantly decreased (p ≤ 0.05), while the antioxidant system markers increased in both liver and brain tissues in the group that received the nano-extract beforehand. In both target tissues, especially in the pre-treated group, the nano-extract reduced the severity of the Etn-caused lesions. During electrophoretic assays, the nano-extract in the pre-treated group prevented the qualitative alterations indicated by the lowest similarity index (SI%) values of the Etn-injected group compared to the normal group. The molecular assay showed that the nano-extract reduced the expression of apoptotic genes that were markedly elevated in the Etn-injected rats, but it was unable to return their values to normalcy. The study concluded that in the group that received nano-extract pretreatment, the biochemical, histopathological, physiological, and molecular abnormalities caused by Etn were reduced by the C. equisetifolia bark gold nano-extract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.